As a leader in cardiovascular research, Bristol Myers Squibb has pioneered the science behind numerous cardiovascular medications that have treated millions of people around the world.
We have a deep, long-standing commitment to cardiovascular disease
For more than 60 years, we have been unwavering in our commitment to cardiovascular disease. This dedication has driven significant advancements in cardiac research and treatment, including the development of multiple therapies, increased awareness of cardiac conditions, and improvements in patient care - from prevention to treatment. These efforts have resulted in improved patient outcomes and have reinforced a strong Bristol Myers Squibb legacy of caring for those affected by cardiovascular conditions.
Our work has consistently addressed - and continues to address - a wide spectrum of cardiovascular diseases, including atrial fibrillation, stroke, pulmonary embolism, arterial thrombosis, heart failure, and heritable cardiomyopathies.
.png)